Novo Nordisk has launched a new installation called "Meet Me in the Middle" as part of an obesity experience. The purpose of the installation is not entirely clear, but it may be related to public health initiatives or awareness about obesity. Other news in the healthcare and pharmaceutical sectors includes discussions about doctor-patient communication, anti-obesity medication, and regulatory issues, but it is unclear how these topics are directly related to the Novo Nordisk installation.